EPIONINE®Bio: Expanscience’s new active ingredient for skin and mind well-being
Laboratoires Expanscience announces the launch of its new holistic active ingredient – EPIONINE®Bio – at the In-Cosmetics 2023 trade show in Barcelona.
“As our mission is to help individuals shape their well-being, we are counting on this new holistic active ingredient to help us fulfill that mission. We are happy to offer EPIONINE®Bio, an organic COSMOS-certified natural active ingredient, to provide a holistic approach to beauty and help individuals feel better about themselves, whether they have skin problems or need an emotional boost”, comments Armelle Le Peniec, Director of the Cosmetic Active Ingredients division of Laboratoires Expanscience.
EPIONINE®Bio, a shift to holistic cosmetics
The organic cosmetic active ingredient EPIONINE®Bio represents an opportunity for cosmetic brands to position themselves on the holistic cosmetic segment, thus contributing to the well-being of individuals by acting on both skin and mind.
The clinical studies1 conducted during the development of EPIONINE®Bio, performed alongside specialists in psychology and neuroscience, showed numerous benefits:
Physical benefits, by strengthening the skin barrier and moisturizing the skin. The daily protection of dry, sensitive skin against in & out stress, which contributes to feelings of discomfort;
And mental benefits, since this active ingredient is able to improve an individual’s emotional state (+18%), quality of life (+21%) and self-esteem (+35%), as well as reduce their psychological stress (-11%).
1 Two clinical studies: the first concerning the improvement of the skin condition between D0 and D28. The second comparing the benefits of Epionine versus placebo after 28 days of use.
“Skin health and well-being are inextricably linked. The symptoms of dry or sensitive skin can affect a person’s well-being, causing stress and having a negative impact on their emotional state. This can create a vicious circle, as stress can in itself be a source of skin problems. Indeed, around 40%* of persons with skin problems also have mental health issues, which are often linked to their skin condition”, adds Armelle Le Peniec.
A natural and organic cosmetic active ingredient which is responsibly sourced
EPIONINE®Bio is an oily active ingredient extracted from the seeds of Camellia oleifera, sustainably sourced in China, rich in precious oil molecules (unsaponifiable) obtained through molecular distillation. This process, which takes place in our Epernon production plant, is more environment-friendly as it requires no solvent. The 100% natural active ingredient is COSMOS certified.
The certification process fully reflects the will of Laboratoires Expanscience to offer cosmetic ingredients of natural origin which are respectful of biodiversity and the environment.
*Mohammad Jafferany, MD, FAPA, Executive Secretary of the Association for Psychoneurocutaneous Medicine, and psychodermatologist. Everyday Health Magazine – 2023
About Laboratoires Expanscience:
You don’t give your all without a good reason. At Expanscience, we are a mission-driven company and our purpose is to help individuals shape their well-being, from the youngest to the oldest. That’s what has motivated us to move forward, carry out research and innovate for over 70 years. Independence is our lifeblood. We’re a French company that is 100% family-owned, with products in over 100 countries and brands like Mustela and Babo Botanicals. For us it’s clear: the well-being of people cannot be separated from that of the planet, and it’s up to all of us to ensure this. Our positive impact on society and the environment has been recognized by the B Corp label, and through our “impACT” CSR program we are undertaking to being a company which has positive, regenerating impact.
Laboratoires Expanscience at a glance:
Founded in 1950
Four businesses: Dermo-Cosmetics, Dermatology, Rheumatology, Cosmetic Active Ingredients
2022 revenue (estimated): €324M, 77% of which from international sales
1098 employees and 14 subsidiaries
3.2% of revenue invested in research and development